Clinical outcomes for Black patients with early-onset breast cancer: An analysis of the National Inpatient Sample.

M Mahija Cheekati (3Ochsner Clinic Foundation, New Orleans, United States) B Ben Brik (1Jefferson Health - New Jersey, Stratford, United States) D Danielle Claire Thor (Jefferson Health New Jersey, Stratford, NJ) T Tony Elias (2Temple University, Philadelphia, United States) V Vineet Polineni (1Jefferson Health - New Jersey, Stratford, United States)

Abstract

11185 Background: Despite recent global decreases in overall cancer incidence, the incidence of early-onset breast cancer (EOBC) is steadily increasing globally. Limited data is available on the comorbid correlations for this unfortunately expanding population. We sought to examine the national inpatient sample database to describe in-hospital outcomes among black patients with EOBC. Methods: Data were extracted from the National Inpatient Sample (NIS) Database for 2019 and 2020. The NIS was searched for hospitalizations of adult patients with EOBC, defined as all-cause breast cancer in patients 50 years old or younger. We then examined the outcomes of patients who self-identified as Black. Multivariate logistic was used to adjust for confounders. The primary outcome was inpatient mortality and secondary outcomes were annotated accordingly. SPSS software was used for statistical analysis, and all results were powered to p<0.001. Results: This study included 10,764 patients with EOBC, of which 2328 (21.6%) were identified as black. Multivariate regression showed that black patients with EOBC had higher inpatient mortality (OR 1.408, CI 1.323-1.498, p<0.001). On secondary analysis, black EOBC patients were more likely to have systemic lupus erythematosus (OR 1.345, CI 1.177-1.538), anemia (OR 1.382, CI 1.355-1.411), thrombocytopenia (OR 1.275, CI 1.230-1.321), hypertension (OR 1.989, CI 1.799-2.200), chronic kidney disease (OR 1.803, CI 1.621-2.004), acute renal failure (OR 1.446, CI 1.379-1.516), pancreatitis (OR 1.291, CI 1.139-1.463), pericarditis (OR 1.200, CI 1.131-1.274), intracranial hemorrhage (OR 1.489, CI 1.264-1.755), chronic obstructive pulmonary disease (OR 1.297, CI 1.216-1.383), severe liver disease (OR 1.351, CI 1.318-1.386), Crohn’s disease (OR 1.275, CI 1.104-1.472), leukemia (OR 1.310, CI 1.098-1.564), all-cause arrhythmias (OR 1.387, CI 1.292-1.489), all-cause shock (OR 1.435, CI 1.260-1.634), all-cause heart block (OR 1.189, CI 1.046-1.352), all-cause sepsis (OR 1.293, CI 1.261-1.326), all-cause coagulopathy (OR 1.355, CI 1.277-1.438), all-cause heart failure (OR 1.659, CI 1.527-1.803), all-cause stroke (OR 1.422, CI 1.319-1.532), and all-cause myocardial infarction (OR 1.638, CI 1.413-1.897). Conclusions: In this nationally representative, population‐based retrospective cohort study, black patients with EOBC were associated with higher mortality and worse outcomes.

Article Details

Volume / Issue Vol. 43, Issue 16_suppl
Published June 01, 2025
Pages 11185-11185
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (5)

M

Mahija Cheekati

3Ochsner Clinic Foundation, New Orleans, United States

B

Ben Brik

1Jefferson Health - New Jersey, Stratford, United States

D

Danielle Claire Thor

Jefferson Health New Jersey, Stratford, NJ

T

Tony Elias

2Temple University, Philadelphia, United States

V

Vineet Polineni

1Jefferson Health - New Jersey, Stratford, United States